This year the Nobel Prize in Physiology or Medicine has gone to Shimon Sakaguchi, Mary E. Brunkow, and Fred Ramsdell for work that reshapes how to understand the immune system — specifically, how it avoids turning against our own bodies.
Their research revealed the mechanism of peripheral immune tolerance, essentially the process that prevents immune cells from attacking healthy tissue. In plain terms: they found the biological “brake” that keeps autoimmunity under control.
They discovered
- Regulatory T cells (Tregs): Sakaguchi identified a special class of immune cells that act as peacekeepers. They suppress rogue immune responses before they spiral into self-destruction.
- The FOXP3 gene: Brunkow and Ramsdell later found the gene that makes those Tregs function. When it’s faulty — as in the rare IPEX syndrome — the immune system goes haywire, confirming just how vital this pathway is.
I think that this isn’t just an academic win but will lay a foundation for future therapy like
- Treat autoimmune diseases by strengthening Tregs in conditions like multiple sclerosis, type 1 diabetes, and rheumatoid arthritis.
- Enhance cancer immunotherapy by temporarily blocking Tregs so immune cells can attack tumors more effectively.
- Improve transplant success by helping doctors better control immune rejection.
A pretty good example of how basic science, decades in the making, can open doors to major medical advances.
~~~ embed:science2/comments/1oev80p/2025_nobel_prize_in_medicine_scientists_uncover/ reddit metadata:fHNjaWVuY2UyfGh0dHBzOi8vd3d3LnJlZGRpdC5jb20vci9zY2llbmNlMi9jb21tZW50cy8xb2V2ODBwLzIwMjVfbm9iZWxfcHJpemVfaW5fbWVkaWNpbmVfc2NpZW50aXN0c191bmNvdmVyL3w= ~~~
This post has been shared on Reddit by @uwelang through the HivePosh initiative.
Don´t be too optimistic regarding future therapies. These discoveries are from the early 2000ies, so >20y old and still autoimmune diseases are more widespread as ever and causal treatment not available.
You’re right — translating discoveries like this into actual treatments takes painfully long, and autoimmune diseases are still a massive challenge.
What’s fascinating, though, is how this early work laid the groundwork for what’s finally moving now — especially in T-reg and immune tolerance research. It’s one of those “slow burn” breakthroughs that only look modest until the next big leap builds on it.